MRTX - Bristol Myers sees $0.35 per share charge as Mirati acquisition completes
2024-01-23 08:51:17 ET
More on Bristol-Myers
- Bristol Myers Squibb: Might Be Approaching A Bottom In 2024
- Bristol-Myers Squibb: Big Dividend Yield, Unloved Big-Pharma Deal
- Bristol-Myers Squibb: I Went Looking For Value And Found A 4.63% Yield Also
- CAR-T therapies to get boxed warning on blood cancer risk
- Bristol's Opdivo + Yervoy combo excels over long term in kidney cancer